◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
COSMOS Pharmaceutical Corporation — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ1 2026Jan 14, 2026Q1 2025Jan 14, 2025Q2 2024May 31, 2024Q2 2023May 31, 2023Q2 2022May 31, 2022Q2 2021May 31, 2021
+Operating Income 20.3B 15.8B -- -- -- --
Operating Margin % 93.4% 91.3% -- -- -- --
+Ordinary Income 21.8B 17.3B -- -- -- --
Revenue Growth % 25.5% -- -- -- -- --
Line ItemQ1 2026Jan 14, 2026Q1 2025Jan 14, 2025Q2 2024May 31, 2024Q2 2023May 31, 2023Q2 2022May 31, 2022Q2 2021May 31, 2021
Current Assets 165.6B 154.3B -- -- -- --
Total Assets 524.8B 476.5B 435.1B 373.3B 346.1B 315.3B
Current Liabilities 220.7B 213.2B -- -- -- --
Total Liabilities 267.3B 245.1B 219.8B 177.9B 166.0B 157.8B
Total Equity 257.5B 231.4B 215.3B 195.4B 180.1B 157.6B
Equity Ratio -- -- 0.49 0.52 0.52 0.50
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...